Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3027432rdf:typepubmed:Citationlld:pubmed
pubmed-article:3027432lifeskim:mentionsumls-concept:C0019159lld:lifeskim
pubmed-article:3027432lifeskim:mentionsumls-concept:C0305052lld:lifeskim
pubmed-article:3027432lifeskim:mentionsumls-concept:C0677582lld:lifeskim
pubmed-article:3027432lifeskim:mentionsumls-concept:C0445202lld:lifeskim
pubmed-article:3027432lifeskim:mentionsumls-concept:C0355642lld:lifeskim
pubmed-article:3027432pubmed:issue5lld:pubmed
pubmed-article:3027432pubmed:dateCreated1987-3-10lld:pubmed
pubmed-article:3027432pubmed:abstractTextA remarkable decline in the morbidity of hepatitis A was observed in the members of the Japan Overseas Cooperation Volunteers (JOCV) following inoculation of these volunteer workers with human immune serum globulin (ISG) once every 4-6 months, a program which was started in 1981 on a voluntary basis. The morbidity rate of hepatitis A declined from 3.5% in 1980 to 0.6% in 1983 and 1984. A significant difference in the morbidity of hepatitis A was observed among those who were not. In addition to precautions about drinking water and fresh or uncooked foods, inoculation with ISG for the prophylaxis against hepatitis A is recommended when non-immune subjects from a developed country travel to or stay in developing countries.lld:pubmed
pubmed-article:3027432pubmed:languageenglld:pubmed
pubmed-article:3027432pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3027432pubmed:citationSubsetIMlld:pubmed
pubmed-article:3027432pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3027432pubmed:statusMEDLINElld:pubmed
pubmed-article:3027432pubmed:monthOctlld:pubmed
pubmed-article:3027432pubmed:issn0021-5031lld:pubmed
pubmed-article:3027432pubmed:authorpubmed-author:OhtaniSSlld:pubmed
pubmed-article:3027432pubmed:authorpubmed-author:OharaHHlld:pubmed
pubmed-article:3027432pubmed:authorpubmed-author:EbisawaIIlld:pubmed
pubmed-article:3027432pubmed:issnTypePrintlld:pubmed
pubmed-article:3027432pubmed:volume56lld:pubmed
pubmed-article:3027432pubmed:ownerNLMlld:pubmed
pubmed-article:3027432pubmed:authorsCompleteYlld:pubmed
pubmed-article:3027432pubmed:pagination229-33lld:pubmed
pubmed-article:3027432pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:3027432pubmed:meshHeadingpubmed-meshheading:3027432-...lld:pubmed
pubmed-article:3027432pubmed:meshHeadingpubmed-meshheading:3027432-...lld:pubmed
pubmed-article:3027432pubmed:meshHeadingpubmed-meshheading:3027432-...lld:pubmed
pubmed-article:3027432pubmed:meshHeadingpubmed-meshheading:3027432-...lld:pubmed
pubmed-article:3027432pubmed:meshHeadingpubmed-meshheading:3027432-...lld:pubmed
pubmed-article:3027432pubmed:meshHeadingpubmed-meshheading:3027432-...lld:pubmed
pubmed-article:3027432pubmed:meshHeadingpubmed-meshheading:3027432-...lld:pubmed
pubmed-article:3027432pubmed:meshHeadingpubmed-meshheading:3027432-...lld:pubmed
pubmed-article:3027432pubmed:meshHeadingpubmed-meshheading:3027432-...lld:pubmed
pubmed-article:3027432pubmed:meshHeadingpubmed-meshheading:3027432-...lld:pubmed
pubmed-article:3027432pubmed:year1986lld:pubmed
pubmed-article:3027432pubmed:articleTitleProphylactic efficacy of immune serum globulin against hepatitis A.lld:pubmed
pubmed-article:3027432pubmed:publicationTypeJournal Articlelld:pubmed